Clinton F Stewart

发表

Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice

Peter J Houghton, P. Houghton, R. Gilbertson, 2004, Cancer Research.

Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Amar Gajjar, Arzu Onar-Thomas, Thomas E Merchant, 2013, Clinical Cancer Research.

Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution.

Daxi Sun, J. Schuetz, M. Adachi, 2007, Cancer research.

Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.

Helen Baines, Stephen Gould, Christine Fuller, 2004, Cancer cell.

Bevacizumab-Induced Transient Remodeling of the Vasculature in Neuroblastoma Xenografts Results in Improved Delivery and Efficacy of Systemically Administered Chemotherapy

M Beth McCarville, A. Davidoff, C. Stewart, 2007, Clinical Cancer Research.

The importance of pharmacokinetic limited sampling models for childhood cancer drug development.

P. Adamson, J. Panetta, L. Iacono, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.

Amar Gajjar, Mehmet Kocak, Arzu Onar-Thomas, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.

Deo Kumar Srivastava, Ching-Hon Pui, Varsha Gandhi, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.

Christopher M Waters, C. Waters, C. Stewart, 2008, American journal of physiology. Cell physiology.

A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomas.

John Carl Panetta, J. Panetta, M. Kirstein, 2003, Mathematical biosciences.

Using Pharmacokinetic and Pharmacodynamic Modeling and Simulation to Evaluate Importance of Schedule in Topotecan Therapy for Pediatric Neuroblastoma

J. Panetta, C. Stewart, Clinton F Stewart, 2008, Clinical Cancer Research.

Whole-Body Physiologically Based Pharmacokinetic Model for Nutlin-3a in Mice after Intravenous and Oral Administration

Fan Zhang, Fangyi Zhu, R Kiplin Guy, 2011, Drug Metabolism and Disposition.

MDM2 antagonist nutlin-3a reverses mitoxantrone resistance by inhibiting breast cancer resistance protein mediated drug transport.

Fan Zhang, C. Stewart, Clinton F Stewart, 2011, Biochemical pharmacology.